AstraZeneca’s Imfinzi alone and in combination fails in Stage IV lung cancer trial
AstraZeneca has announced its Phase III MYSTIC trial of Imfinzi alone and Imfinzi combined with tremelimumab in untreated non-small cell...
Trending:
-
![]()
Unreal Engine: from gaming to ground-breaking cures
-
![NHS staff shortage]()
UK health service may face shortage of 350,000 staff by 2030
-
![draft Brexit withdrawal agreement pharma]()
Draft Brexit withdrawal agreement: what does it mean for the pharma industry?
-
![]()
Using AI to personalise drug combination therapy
-
![]()
South Korean regulator publishes final ruling on Samsung BioLogics’ accounting violations
-
![obesity and depression]()
Genomic study directly links depression to obesity
Expert commentary & analysis from GlobalData
World Antibiotic Awareness Week: WHO highlights need for antimicrobial stewardship
Apellis unlikely to resume AMD trial before 2019
Zafgen’s ZGN-1061 for T2D and obesity leaves experts uncertain
Diabetes Awareness Month: the unmet needs that remain
Most Read
Company releases
See Innovative Micronisation and Containment Solutions at CPhI
FPS has announced it will be showcasing its innovations on micronisation and containment at CphI India.
Webinar: Conquering the Chaos
IKA Wins German Design Award for easy-to-clean disperser
The high-performance IKA T 25 easy-to-clean disperser is one of the first of its kind for use in research, product...
Medelpharm Launches New Benchtop Tableting Instrument
Cutting through the Industry 4.0 Paradigm Webinar
Zenith Technology has announced that its global director David Staunton will be hosting a webinar on...
Company whitepapers
The Nymi™ Band
Nymi™Getting Acquainted with the XRF Theory
Malvern PanalyticalDose Delivery Methodology by Sterigenics’ CompactCell
SterigenicsThe Future of the Pharmaceutical Industry
NSF International, Pharma BiotechIKA Case Study: Developing Sustainable Textiles
IKA-Werke GmbH & CoWeibel CDS: Safer, Easier, and Faster Drug Delivery
Weibel CDSA One-Stop Solution for Biopharmaceutical Manufacturing
Stelis BioSource®Company A-Z
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Projects
Medicago’s Vaccine Production Facility, Quebec, Canada
Medicago is constructing a new influenza vaccine production facility in the Estimauville Innovation Area in Quebec City, Canada.
GRAM’s Pharmaceutical Manufacturing Facility, Michigan, US
Boehringer Ingelheim’s Biopharmaceutical Production Facility in Vienna, Austria
Lonza’s Ibex Biomanufacturing Complex in Visp, Switzerland
MSD’s Biologics Manufacturing Facility, Swords, Ireland
Clinical Trials
Genomic profiling offers hope for rare cancer treatments
A clinical trial led by Walter and Eliza Hall Institute of Medical Research in Australia has demonstrated that genomic profiling could help match rare cancer...
Foamix publishes top line phase III results for rosacea drug
Lilly’s Trulicity shows superiority in reducing CV events in type 2 diabetes
Nurocor partners with Intilaris to improve clinical trial planning process
Roche reports positive results from IMpower130 study of Tecentriq
Drug Development
AstraZeneca’s Imfinzi alone and in combination fails in Stage IV lung cancer trial
AstraZeneca has announced its Phase III MYSTIC trial of Imfinzi alone and Imfinzi combined with tremelimumab in untreated non-small cell lung cancer (NSCLC) patients failed...
United Therapeutics reaches $1.2bn licensing deal with Arena
CRISPR and MaxCyte sign licensing deal for cancer therapies
Vectura and Hikma to jointly develop generic versions of GSK’s Ellipta
Provention Bio to develop Amgen’s celiac disease candidate
Market Data
M&As this week: Nestle Health, InvaGen, Takeda
Nestle Health has acquired a 19% stake in Aimmune Therapeutics for $98m.
Deals this week: Swedish Orphan Biovitrum, Vectura
UK health service may face shortage of 350,000 staff by 2030
Pfizer loses Lyrica patent case in UK Supreme Court
WHO finds wide differences in global antibiotics consumption
Technology
Elsevier introduces cloud-based platform for life sciences companies
Analytics firm Elsevier has introduced a new Cloud-based platform to support life sciences companies in addressing the changes occurring in modern research and development (R&D).
Otsuka expands digital medicines alliance with Proteus Digital
Sandoz launches second Healthcare Access Challenge
Hong Kong researchers create tiny soft robot for drug delivery
Innovate UK funds AI drug discovery platform